Mirae Asset Global Investments Co. Ltd. Boosts Stock Holdings in Celsius Holdings, Inc. (NASDAQ:CELH)

Mirae Asset Global Investments Co. Ltd. increased its position in shares of Celsius Holdings, Inc. (NASDAQ:CELH) by 115.0% in the 4th quarter, HoldingsChannel reports. The firm owned 53,881 shares of the company’s stock after purchasing an additional 28,819 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Celsius were worth $2,963,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in the company. BlackRock Inc. raised its holdings in Celsius by 0.9% during the first quarter. BlackRock Inc. now owns 6,435,150 shares of the company’s stock worth $355,091,000 after purchasing an additional 58,764 shares in the last quarter. Vanguard Group Inc. raised its holdings in Celsius by 18.7% during the third quarter. Vanguard Group Inc. now owns 4,846,599 shares of the company’s stock worth $831,676,000 after purchasing an additional 762,087 shares in the last quarter. Capital International Investors purchased a new position in Celsius during the first quarter worth about $93,034,000. State Street Corp raised its holdings in Celsius by 2.8% during the first quarter. State Street Corp now owns 1,566,165 shares of the company’s stock worth $145,559,000 after purchasing an additional 42,821 shares in the last quarter. Finally, Invesco Ltd. raised its holdings in Celsius by 5.7% during the third quarter. Invesco Ltd. now owns 1,167,995 shares of the company’s stock worth $200,428,000 after purchasing an additional 62,483 shares in the last quarter. 60.95% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Celsius

In other Celsius news, Director Caroline S. Levy sold 20,000 shares of the business’s stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $94.77, for a total transaction of $1,895,400.00. Following the completion of the transaction, the director now directly owns 37,891 shares of the company’s stock, valued at approximately $3,590,930.07. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, Director Caroline S. Levy sold 20,000 shares of the company’s stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $94.77, for a total value of $1,895,400.00. Following the completion of the sale, the director now directly owns 37,891 shares of the company’s stock, valued at approximately $3,590,930.07. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Nicholas Castaldo sold 165,000 shares of the company’s stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $83.33, for a total transaction of $13,749,450.00. Following the completion of the sale, the director now directly owns 352,864 shares of the company’s stock, valued at $29,404,157.12. The disclosure for this sale can be found here. Insiders sold a total of 1,094,783 shares of company stock valued at $62,679,671 in the last quarter. Insiders own 2.70% of the company’s stock.

Celsius Price Performance

Celsius stock opened at $70.97 on Thursday. Celsius Holdings, Inc. has a 12-month low of $28.10 and a 12-month high of $99.62. The company has a market capitalization of $16.39 billion, a price-to-earnings ratio of 91.77, a price-to-earnings-growth ratio of 2.14 and a beta of 1.86. The firm’s fifty day moving average price is $78.36 and its 200 day moving average price is $64.03.

Celsius (NASDAQ:CELH) last released its earnings results on Thursday, February 29th. The company reported $0.17 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.01. The company had revenue of $347.44 million during the quarter, compared to the consensus estimate of $326.77 million. Celsius had a net margin of 17.21% and a return on equity of 131.58%. The company’s revenue was up 95.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.01 EPS. Analysts forecast that Celsius Holdings, Inc. will post 1.09 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have weighed in on the stock. Stifel Nicolaus upped their target price on shares of Celsius from $67.00 to $90.00 and gave the stock a “buy” rating in a research report on Friday, March 1st. Morgan Stanley restated an “equal weight” rating and set a $75.00 target price on shares of Celsius in a research report on Wednesday, March 27th. Bank of America lowered shares of Celsius from a “buy” rating to a “neutral” rating and set a $65.00 target price on the stock. in a research report on Friday, January 19th. Maxim Group upped their target price on shares of Celsius from $100.00 to $110.00 and gave the stock a “buy” rating in a research report on Monday, April 1st. Finally, Wedbush upped their target price on shares of Celsius from $75.00 to $90.00 and gave the stock an “outperform” rating in a research report on Monday, March 4th. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $85.10.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.